A point-of-care rapid diagnostic test for tuberculosis (TB) has been developed by a multinational team of scientists led by researchers at Stellenbosch University.
“This low-cost screening test has the potential to significantly speed up TB diagnosis in resource-limited setting,” says co-inventor, Prof Gerhard Walzl of Stellenbosch University’s Faculty of Medicine and Health Sciences. The test is conducted on blood obtained from a finger-prick and can make a TB diagnosis in less than an hour.
“Health care workers with minimal training will be able use the test at grass-roots level and get immediate access to screening test results,” says Walzl. The diagnostic test is a hand-held, battery-operated instrument that will measure chemicals in the blood of people with possible TB.
The device is currently in developmental phase and its accuracy and efficacy will be tested in five African countries over the next three years by the ScreenTB consortium, a team of TB experts from eight African and European partnering institutions.
Other recent advances in TB diagnostics have radically improved diagnostic times, but high costs and the sophisticated equipment required have made this technology inaccessible to many.
“People in remote areas with high TB incidence still do not benefit from the newer developments and face long diagnostic delays and often multiple return visits to clinics before they are diagnosed,” says Walzl.
The new test will be able to provide near-immediate results that will enable a person with TB to be diagnosed and started on treatment during a single visit to a health care facility.
The Latest on: Tuberculosis
via Google News
The Latest on: Tuberculosis
- New blood test could be used to help millions of people infected with tuberculosison October 23, 2019 at 11:11 am
More than 10 million people around the world have active tuberculosis (ATB), and every year more than a million die from it. The majority of patients live in low-resource countries where diagnosing ...
- Tuberculosis treatment completely free of charge in Iranon October 23, 2019 at 10:09 am
The number of people diagnosed with tuberculosis (TB) in the country estimated at 8,713, 54 percent of which are male and 46 percent are female, she regretted, adding, about 16.3 percent of the cases ...
- Anti-arthritis drug can stop tuberculosis bacillus from infecting blood stem cellson October 23, 2019 at 9:05 am
Immunologist Johan Van Weyenbergh (KU Leuven) and his Belgian-Brazilian colleagues have shown that a drug used to fight arthritis also stops the process that allows the tuberculosis bacillus to infect ...
- CWRU, UH researcher lands $30 million NIH contract to advance tuberculosis researchon October 23, 2019 at 7:35 am
An infectious disease researcher at Case Western Reserve University and University Hospitals, along with a team of collaborators, has been awarded a $30 million contract by the National Institutes of ...
- Publisher Correction: M. tuberculosis infection and antigen specific cytokine response in healthcare workers frequently exposed to tuberculosison October 23, 2019 at 1:37 am
The original version of this Article contained errors in the affiliation list, where Affiliations 1 and 2 were inverted and the original Affiliation 2 was given as ‘Unité de Recherches et de ...
- Kiwi researchers in breakthrough treatment for tuberculosison October 22, 2019 at 4:20 pm
October 23, 2019 – A team of medical researchers based at the University of Auckland (UoA), who have been working for nearly 15 years in partnership with the international non-profit TB Alliance to ...
- Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIVon October 22, 2019 at 7:09 am
Tuberculosis (TB) causes more deaths in people living with HIV than any other disease, with more than 300,000 deaths in 2017. When detected, early TB can be treated effectively; however, people with ...
- Tuberculosis cases hit record U.S. low, on decline globallyon October 17, 2019 at 6:48 pm
The United States last year recorded its lowest number of cases of tuberculosis, and many other countries also reported a decrease in cases of the deadly infectious disease. For 2018, the U.S.
- Tuberculosis Drugs Market Growth by 2024: Revenue, Gross Margin and Market Shares, Demands, Types, Industry Demandson October 17, 2019 at 7:30 am
Oct 17, 2019 (Industry News Wire via COMTEX) -- Tuberculosis Drugs Market Summary 2019 : Tuberculosis Drugs are used to treat tuberculosis.Tuberculosis is a chronic condition that is often undermined, ...
- Doctors Without Borders presses Johnson & Johnson to slash price of tuberculosis drugon October 14, 2019 at 4:03 pm
Doctors Without Borders is calling on Johnson & Johnson to halve the price of a lifesaving tuberculosis drug, called bedaquline, to make it more accessible to patients around the world. Currently, a ...
via Bing News